BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8583345)

  • 1. Models of 5-hydroxytryptamine receptors. A review.
    Chilmonczyk Z
    J Pharm Pharmacol; 1995 Oct; 47(10):791-801. PubMed ID: 8583345
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
    López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
    Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT7 receptor: orphan found.
    Eglen RM; Jasper JR; Chang DJ; Martin GR
    Trends Pharmacol Sci; 1997 Apr; 18(4):104-7. PubMed ID: 9149537
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
    Newman-Tancredi A; Cussac D; Marini L; Millan MJ
    Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor].
    Lefebvre H
    Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490
    [No Abstract]   [Full Text] [Related]  

  • 6. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
    Terrón JA
    Proc West Pharmacol Soc; 1996; 39():23-5. PubMed ID: 8895957
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the putative 5-HT7 receptor mediating direct relaxation to 5-hydroxytryptamine in canine cerebral blood vessels.
    Terrón JA
    Ann N Y Acad Sci; 1998 Dec; 861():283. PubMed ID: 9928292
    [No Abstract]   [Full Text] [Related]  

  • 10. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure and signalling properties of 5-HT receptors: an endless diversity?
    Martin GR; Eglen RM; Hamblin MW; Hoyer D; Yocca F
    Trends Pharmacol Sci; 1998 Jan; 19(1):2-4. PubMed ID: 9509891
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological and molecular characterization of 5-hydroxytryptamine(7) receptors in the rat adrenal gland.
    Contesse V; Lenglet S; Grumolato L; Anouar Y; Lihrmann I; Lefebvre H; Delarue C; Vaudry H
    Mol Pharmacol; 1999 Sep; 56(3):552-61. PubMed ID: 10462543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
    Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
    Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
    Kuipers W; Van Wijngaarden I; Ijzerman AP
    Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex role of serotonin and 5-HT receptors in chronic pain.
    Bardin L
    Behav Pharmacol; 2011 Sep; 22(5-6):390-404. PubMed ID: 21808193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.
    Marazziti D; Baroni S; Borsini F; Picchetti M; Vatteroni E; Falaschi V; Catena-Dell'Osso M
    Curr Med Chem; 2013; 20(3):371-7. PubMed ID: 23157629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
    Wesołowska A; Jastrzębska-Więsek M
    Int Rev Neurobiol; 2011; 96():49-71. PubMed ID: 21329784
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonism of the relaxant 5-HT receptor in the dog basilar artery by the high-affinity 5-HT7 receptor ligand, LY215840.
    Terrón JA
    Proc West Pharmacol Soc; 1998; 41():129-30. PubMed ID: 9836268
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of 5-HT1A receptors in the consolidation of learning in cognitively impaired rats.
    Meneses A; Terrón JA; Hong E
    Ann N Y Acad Sci; 1998 Dec; 861():286-7. PubMed ID: 9928294
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of 5-hydroxytryptamine receptors].
    Fontaine J
    J Pharm Belg; 1996; 51(3):141-51. PubMed ID: 8778347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.